tirzepatide weight loss rate outperformed semaglutide weight-loss drug results in real world patients, study shows TrimRX | Tirzepatide Results Timeline:

Hydration is everything

GIP signalling adds more insulin support and may ease the nausea that GLP-1 alone can cause

The blend is still a once-daily injection from the same compounding pharmacy, with broader anti-inflammatory coverage where the surgical field calls for it

Results were published in the New England Journal of Medicine in May 2025

Tirzepatide 10mg/mL Inject Subcutaneously This product is no longer available Indications: Blood sugar control, Weight loss, Cardiovascular risk reduction, Lowering of A1c levels, Improved insulin sensitivity, Appetite regulation, Potential for once-weekly dosing, Positive impact on cardiovascular outcomes, Lower risk of hypoglycemia Details: Inject Subcutaneously 1 Vial Introducing Tirzepatide: A Revolutionary Breakthrough in Diabetes Management

This energy-burning mechanism is an additional component of this therapy, which is not present in semaglutide and tirzepatide therapy